For instance, in prostate cancer, SOX2 promotes tumorigenesis and decreases apoptosis by activating the EGFR/PI3K/AKT pathway [35], and plays a critical role in EGFR-mediated self-renewal of human prostate cancer stem-like cells [36]. This evidence concerns the gene AKT1 and prostate carcinoma.